Kytopen
kytopen.comLocations
Cambridge, MA, USA · United States
industry
Software · Transportation · Health · Biotechnology · DeepTech
Size
11-50 employees
Stage
Series A
founded in
2017
Bio & pharma
hospital & health care
Merck
horizons ventures
alexandria venture investments
Massventures
massachusetts clean energy center
2. 11-50
Kytopen is a developer of a cell therapy platform designed for non-viral delivery of molecules into hard-to-transfect immune cells. The company's technology combines microfluidics and automation to make non-viral delivery of molecules easier, faster and cheaper through an automated cell engineering platform, enabling researchers to find new discoveries in biology that will lead to cost effective cell and gene therapies.
Something looks off?Open jobs at Kytopen
